Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022

Jiahua Liu, Junnan Ma, Jiarong Zhang, Chengming Li, Bowen Yu, Hyok Chol Choe, Kaiyue Ding, Liu Zhang, Zhang Lin, Lin ZhangFrontiers in Oncology 2023 · DOI · OpenAlex

Introduction

This article serves as a formal corrigendum for the research paper titled "Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022," originally published in Frontiers in Oncology. The primary objective of this notice is to rectify an omission in the original publication's funding statement, ensuring full transparency and adherence to academic standards.

Frontiers in Oncology Logo

The Nature of the Correction

In academic publishing, accurate disclosure of financial support is vital for identifying potential conflicts of interest and recognizing the institutions driving scientific innovation. Following the publication of the original study, the authors identified that the "Funding" section was incomplete.

Check for updates icon

The updated funding statement now includes a previously omitted grant: the Dalian Medical University Foundation for Teaching Reform Project of Undergraduate Innovative Talents Training (No. 111906010210). This addition suggests that the research may have played a role in undergraduate medical education or innovative talent training initiatives at the university level.

Impact on Research Findings

The authors emphasize that this administrative update does not alter the scientific results, data analysis, or conclusions of the original study. The original research remains a valid bibliometric mapping of a decade of trends in ovarian cancer drug resistance, specifically focusing on mechanisms involving PARP inhibitors and bevacizumab.

As established in the original work, the study utilized specialized software tools to synthesize data:

  • CiteSpace: Used for visualizing trends and patterns in scientific literature.
  • VOSviewer: Used for constructing bibliometric networks, such as co-authorship and keyword co-occurrence.

Finalized Funding Statement

With this correction, the research is officially credited to the following sources:

  1. National Natural Science Foundation of China (No. 81873195)
  2. Liaoning Revitalization Talents Program (XLYC1907113)
  3. Natural Science Foundation of Liaoning Province (2023010109-JH2/1013)
  4. Distinguished Young Scholars in Dalian (2022RJ19)
  5. Dalian Medical University Foundation for Teaching Reform Project of Undergraduate Innovative Talents Training (111906010210)

This corrigendum ensures that the scholarly record is accurate for future citations and institutional audits.

Summary updated

Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1173863.].
BibTeX
@inproceedings{liu2023corrigendum,
  author = {Jiahua Liu and Junnan Ma and Jiarong Zhang and Chengming Li and Bowen Yu and Hyok Chol Choe and Kaiyue Ding and Liu Zhang and Zhang Lin and Lin Zhang and Lin Zhang},
  title = {{Corrigendum: Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022}},
  booktitle = {Frontiers in Oncology},
  year = {2023},
  doi = {10.3389/fonc.2023.1228879},
}
Figure